In March 2011 the National Anti-Doping Agency of India (INADA) has reported an anti-doping rule violation against the Athlete after her A and B samples tested positive for the prohibited substance clenbuterol.
INADA notified the Athlete and ordered a provisional suspension.
The Athlete admitted that she had used prescription medicines as treatment for painful menstrual cycle.
Considering the circumstances the Anti-Doping Disciplinary Panel of India (ADDPI) decided to impose a 10 month period of ineligibility on the Athlete.
Hereafter WADA appealed the ADDPI decision with the Anti-Doping Appeal Panel of India (ADAPI).
WADA argued that an anti-doping rule violation was established; the Athlete did not obtain a TUE; the medication prescription shown to the Disciplinary Panel does not contain a prohibited substance; and the Athlete’s disease does not need to be treated with anabolic agents.
Considering the facts in this case the Appeal Panel concludes that there are no grounds for no fault or negligence. Therefore the Anti-Doping Appeal Panel of India decides to set aside the ADDPI decision and to impose a 2 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 21 March 2011.
